Strata Critical Medical, Inc. earned $0.50 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a loss of $0.30 per diluted share. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Strata Critical Medical, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)$0.50
YoYn/m
Ticker history: BLDE became
SRTA
(Strata Critical Medical, Inc.) on .
Earlier news and filings retain their original names and dates.
View BLDE history.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Strata Critical Medical, Inc. earned $0.50 per diluted share in fiscal year 2025.
Strata Critical Medical, Inc. (SRTA) reported a loss of $0.35 per diluted share in fiscal year 2024 and $0.50 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Strata Critical Medical, Inc. (SRTA) reported a loss of $0.30 per diluted share over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Across the 7 fiscal years this page covers, Strata Critical Medical, Inc. (SRTA) diluted earnings per share went from -$0.43 in fiscal year 2019 to $0.50 in fiscal year 2025.
Strata Critical Medical, Inc. (SRTA) reported -$0.09 in diluted earnings per share in Q3 2026. This represents a decrease of 112.9% from the same quarter a year earlier.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Strata Critical Medical, Inc. (SRTA) reported on that line in every period on record.
